Source:http://linkedlifedata.com/resource/pubmed/id/21837934
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2011-8-15
|
pubmed:abstractText |
Since 2004, the US Food And Drug Administration and the European Medicine Agency are giving warnings about cocaine adulterated with levamisole. Levamisole is primarily used as an anti-helminthic. One of the side-effects of levamisole is a decreased bone marrow function. Herein we describe the first case of agranulocytosis and neutropenic fever due to cocaine adulterated with levamisole reported in Europe.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0001-5512
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
66
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
226-7
|
pubmed:meshHeading |
pubmed-meshheading:21837934-Adult,
pubmed-meshheading:21837934-Agranulocytosis,
pubmed-meshheading:21837934-Antinematodal Agents,
pubmed-meshheading:21837934-Cocaine,
pubmed-meshheading:21837934-Cocaine-Related Disorders,
pubmed-meshheading:21837934-Drug Contamination,
pubmed-meshheading:21837934-Female,
pubmed-meshheading:21837934-Gas Chromatography-Mass Spectrometry,
pubmed-meshheading:21837934-Humans,
pubmed-meshheading:21837934-Levamisole
|
pubmed:articleTitle |
A warning about agranulocytosis with the use of cocaine adulterated with levamisole.
|
pubmed:affiliation |
Department of Haematology, Antwerp University Hospital, Edegem, Belgium. stany.perkisas@uza.be
|
pubmed:publicationType |
Journal Article,
Case Reports
|